Overview

The discovery of genetic and immunologic biomarkers in non-small cell lung cancer (NSCLC) and the increasing development of biomarker-specific targeted therapies and immunotherapies have transformed the treatment landscape of advanced NSCLC. However, rapid changes in the field also present the challenge of translating recent trial data and the latest guideline recommendations into clinical practice. 

This symposium will be immersive, with NSCLC patient cases incorporated throughout the presentation. Attendees of this symposium will be provided with evidence-based information on the latest developments in NSCLC, including updates on biomarker testing for guided selection of targeted therapy and immunotherapy agents. This symposium will also explore the importance of biomarker testing to guide treatment at therapy initiation and upon disease progression. Additionally, strategies for the pharmacist to incorporate the latest advances in biomarker-driven NSCLC therapy into their clinical practices will be included.  

Speakers

Josiah Land, PharmD, BCOP

Clinical Pharmacy Specialist
Thoracic Medical Oncology Team
Memorial Sloan Kettering Cancer Center
New York, New York View Full Bio

Joshua Bauml, MD

Assistant Professor of Medicine
Division of Hematology/Oncology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
View Full Bio

Accreditation

Accreditation

In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacy (ACPE)

This application-based activity is approved for 1.5 contact hours (.15 CEUs) of continuing pharmacy education credit (JA0007101-0000-19-015-L01-P).

Upon completion of a CE request form, pharmacy credit will be reported directly to the National Association of Boards of Pharmacy® (NABP®) CPE Monitor electronic CE tracking system.

Acknowledgement

This activity is supported by an independent educational grant from AstraZeneca.